REGENERX BIOPHARMACEUTICALS INC Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2013 to Q1 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Regenerx Biopharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2013 to Q1 2023.
  • Regenerx Biopharmaceuticals Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending March 31, 2023 was 144M shares, unchanged year-over-year.
  • Regenerx Biopharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 144M shares, a 3.58% increase from 2021.
  • Regenerx Biopharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 139M shares, a 3.93% increase from 2020.
  • Regenerx Biopharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2020 was 133M shares, a 1.82% increase from 2019.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 144M 0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 144M +4.96M +3.58% Oct 1, 2022 Dec 31, 2022 10-K 2023-04-11
Q3 2022 144M +67.1K +0.05% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 144M +9.89M +7.4% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-12
Q1 2022 144M +10M +7.51% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 139M +5.24M +3.93% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-11
Q3 2021 143M +10M +7.52% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 134M +214K +0.16% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 134M +417K +0.31% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 133M +2.39M +1.82% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 133M +1.94M +1.47% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 133M +2.18M +1.66% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 133M +3.52M +2.72% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 131M +10.3M +8.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-02
Q3 2019 132M +8.58M +6.98% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 131M +11.6M +9.72% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 130M +18M +16.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 121M +13.3M +12.4% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-20
Q3 2018 123M +16M +15% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 120M +12.8M +12% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 112M +4.83M +4.53% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 107M +656K +0.61% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 107M +5.1M +5.01% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 107M +5.11M +5.02% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 107M +5.15M +5.06% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 107M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-29
Q3 2016 102M +147K +0.15% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 102M +244K +0.24% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-21
Q1 2016 102M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q3 2015 102M +5.67M +5.91% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 102M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-22
Q3 2014 96M +14.2M +17.4% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q3 2013 81.7M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.